.BETA.2- And .BETA.3-Adrenoceptor Polymorphisms Relate to Subsequent Weight Gain and Blood Pressure Elevation in Obese Normotensive Individuals

Hypertension Research - United Kingdom
doi 10.1291/hypres.29.951
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Hypertension

Related search

Resistance to Beta-Adrenoceptor Stimulatnts.

BMJ
1972English

Acute and Chronic Regulation of Ob mRNA Levels by .BETA.3-Adrenoceptor Agonists in Obese Yellow KK Mice.

Endocrine Journal
EndocrinologyMetabolismDiabetes
1998English

Superacute Phase Blood Pressure Elevation May Relate to Massive Hematoma in Hypertensive Putaminal Hemorrhage.

Keio Journal of Medicine
Medicine
1997English

Beta-Blockers, Hypertension, and Weight Gain: The Farmer, the Chicken, and the Egg

2020English

Evaluation of the Beta 2 Adrenoceptor Agonist/Antagonist Activity of Formoterol and Salmeterol.

Thorax
PulmonaryRespiratory Medicine
1996English

Metabolic Health in Normal-Weight and Obese Individuals

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Metabolic and Cardiovascular Side Effects of the Beta 2-Adrenoceptor Agonists Salbutamol and Rimiterol.

British Journal of Clinical Pharmacology
Pharmacology
1980English

Regions of Beta 2 and Beta 4 Responsible for Differences Between the Steady State Dose-Response Relationships of the Alpha 3 Beta 2 and Alpha 3 Beta 4 Neuronal Nicotinic Receptors

Journal of General Physiology
Physiology
1995English

Association of Weight Gain and Fifteen Adipokines With Declining Beta-Cell Function in Mexican Americans

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy